226 related articles for article (PubMed ID: 21349321)
1. In silico identification of novel protective VSG antigens expressed by Trypanosoma brucei and an effort for designing a highly immunogenic DNA vaccine using IL-12 as adjuvant.
Akhoon BA; Slathia PS; Sharma P; Gupta SK; Verma V
Microb Pathog; 2011; 51(1-2):77-87. PubMed ID: 21349321
[TBL] [Abstract][Full Text] [Related]
2. VSG 117 gene is conservatively present and early expressed in Trypanosma evansi YNB stock.
Jia Y; Guo L; Zhao X; Suo X
Exp Parasitol; 2012 May; 131(1):75-9. PubMed ID: 22465499
[TBL] [Abstract][Full Text] [Related]
3. Probabilistic order in antigenic variation of Trypanosoma brucei.
Morrison LJ; Majiwa P; Read AF; Barry JD
Int J Parasitol; 2005 Aug; 35(9):961-72. PubMed ID: 16000200
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Trypanosoma brucei gambiense variant surface glycoprotein LiTat 1.5.
Van Nieuwenhove L; Rogé S; Lejon V; Guisez Y; Büscher P
Genet Mol Res; 2012 May; 11(2):1260-5. PubMed ID: 22614354
[TBL] [Abstract][Full Text] [Related]
5. Capturing the variant surface glycoprotein repertoire (the VSGnome) of Trypanosoma brucei Lister 427.
Cross GA; Kim HS; Wickstead B
Mol Biochem Parasitol; 2014 Jun; 195(1):59-73. PubMed ID: 24992042
[TBL] [Abstract][Full Text] [Related]
6. Trypanosomes expressing a mosaic variant surface glycoprotein coat escape early detection by the immune system.
Dubois ME; Demick KP; Mansfield JM
Infect Immun; 2005 May; 73(5):2690-7. PubMed ID: 15845470
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the ligand-binding site of the transferrin receptor in Trypanosoma brucei demonstrates a structural relationship with the N-terminal domain of the variant surface glycoprotein.
Salmon D; Hanocq-Quertier J; Paturiaux-Hanocq F; Pays A; Tebabi P; Nolan DP; Michel A; Pays E
EMBO J; 1997 Dec; 16(24):7272-8. PubMed ID: 9405356
[TBL] [Abstract][Full Text] [Related]
8. The in vivo dynamics of antigenic variation in Trypanosoma brucei.
Mugnier MR; Cross GA; Papavasiliou FN
Science; 2015 Mar; 347(6229):1470-3. PubMed ID: 25814582
[TBL] [Abstract][Full Text] [Related]
9. Antigenic variation during the developmental cycle of Trypanosoma brucei.
Hajduk SL
J Protozool; 1984 Feb; 31(1):41-7. PubMed ID: 6204043
[TBL] [Abstract][Full Text] [Related]
10. Antigenic diversity is generated by distinct evolutionary mechanisms in African trypanosome species.
Jackson AP; Berry A; Aslett M; Allison HC; Burton P; Vavrova-Anderson J; Brown R; Browne H; Corton N; Hauser H; Gamble J; Gilderthorp R; Marcello L; McQuillan J; Otto TD; Quail MA; Sanders MJ; van Tonder A; Ginger ML; Field MC; Barry JD; Hertz-Fowler C; Berriman M
Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3416-21. PubMed ID: 22331916
[TBL] [Abstract][Full Text] [Related]
11. Variant surface glycoprotein from Trypanosoma evansi is partially responsible for the cross-reaction between Trypanosoma evansi and Trypanosoma vivax.
Uzcanga GL; Perrone T; Noda JA; Pérez-Pazos J; Medina R; Hoebeke J; Bubis J
Biochemistry; 2004 Jan; 43(3):595-606. PubMed ID: 14730963
[TBL] [Abstract][Full Text] [Related]
12. VSGs Expressed during Natural T. b. gambiense Infection Exhibit Extensive Sequence Divergence and a Subspecies-Specific Bias towards Type B N-Terminal Domains.
So J; Sudlow S; Sayeed A; Grudda T; Deborggraeve S; Ngoyi DM; Desamber DK; Wickstead B; Lejon V; Mugnier MR
mBio; 2022 Dec; 13(6):e0255322. PubMed ID: 36354333
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma evansi: identification and characterization of a variant surface glycoprotein lacking cysteine residues in its C-terminal domain.
Jia Y; Zhao X; Zou J; Suo X
Exp Parasitol; 2011 Jan; 127(1):100-6. PubMed ID: 20599437
[TBL] [Abstract][Full Text] [Related]
14. A structural motif in the variant surface glycoproteins of Trypanosoma brucei.
Blum ML; Down JA; Gurnett AM; Carrington M; Turner MJ; Wiley DC
Nature; 1993 Apr; 362(6421):603-9. PubMed ID: 8464512
[TBL] [Abstract][Full Text] [Related]
15. Application of long read sequencing to determine expressed antigen diversity in Trypanosoma brucei infections.
Jayaraman S; Harris C; Paxton E; Donachie AM; Vaikkinen H; McCulloch R; Hall JPJ; Kenny J; Lenzi L; Hertz-Fowler C; Cobbold C; Reeve R; Michoel T; Morrison LJ
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007262. PubMed ID: 30943202
[TBL] [Abstract][Full Text] [Related]
16. Trypanosoma brucei: immunisation with plasmid DNA encoding invariant surface glycoprotein gene is able to induce partial protection in experimental African trypanosomiasis.
Lança AS; de Sousa KP; Atouguia J; Prazeres DM; Monteiro GA; Silva MS
Exp Parasitol; 2011 Jan; 127(1):18-24. PubMed ID: 20599996
[TBL] [Abstract][Full Text] [Related]
17. Bloodstream form Trypanosome plasma membrane proteins: antigenic variation and invariant antigens.
Schwede A; Carrington M
Parasitology; 2010 Dec; 137(14):2029-39. PubMed ID: 20109254
[TBL] [Abstract][Full Text] [Related]
18. Genetics of resistance to the African trypanosomes. VI. Heredity of resistance and variable surface glycoprotein-specific immune responses.
De Gee AL; Levine RF; Mansfield JM
J Immunol; 1988 Jan; 140(1):283-8. PubMed ID: 3121739
[TBL] [Abstract][Full Text] [Related]
19. Control of parasitemia and survival during Trypanosoma brucei brucei infection is related to strain-dependent ability to produce IL-4.
Bakhiet M; Jansson L; Büscher P; Holmdahl R; Kristensson K; Olsson T
J Immunol; 1996 Oct; 157(8):3518-26. PubMed ID: 8871651
[TBL] [Abstract][Full Text] [Related]
20. Independent regulation of B cell responses to surface and subsurface epitopes of African trypanosome variable surface glycoproteins.
Reinitz DM; Mansfield JM
J Immunol; 1988 Jul; 141(2):620-6. PubMed ID: 2454998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
